...
首页> 外文期刊>The Journal of Nuclear Medicine >Evaluation of 18F-FDG PET with Bladder Irrigation in Patients with Uterine and Ovarian Tumors
【24h】

Evaluation of 18F-FDG PET with Bladder Irrigation in Patients with Uterine and Ovarian Tumors

机译:膀胱和卵巢肿瘤患者膀胱灌注18F-FDG PET的评估

获取原文

摘要

id="p-1">The purpose of this study was to evaluate PET using 18F-FDG for gynecologic lesions with continuous bladder irrigation to eliminate artifacts from the 18F-FDG activity in the bladder. >Methods: Forty-one patients were studied. They had 23 cervical uterine lesions (15 cases of cancer, 5 recurrences, 3 nonrecurrences); 8 cases of uterine corpus cancer, including 2 recurrences; and 10 ovarian masses (6 malignant, 4 nonmalignant). All cases of cancer were histologically proven; however, 2 cases of nonrecurrent uterine cervical carcinomas were diagnosed by clinical course. Continuous bladder irrigation was performed 35-55 min after intravenous administration of 185-370 MBq 18F-FDG, and an emission scan was obtained 40-55 min after intravenous administration. Standardized uptake value (SUV) was used to estimate the degree of 18F-FDG uptake quantitatively. >Results: After bladder irrigation, the 18F-FDG activity in the urinary tract was eliminated in 33 patients, so that detection of tumor 18F-FDG accumulation was easy. Two patients showed residual activity in the urinary bladder, and 6 patients showed activity in the ureter. An artifact was seen in 1 patient with residual activity in the urinary bladder caused by insufficient irrigation. However, these residual activities had no influence on detecting 18F-FDG accumulation in tumor. The mean (?±SD) of SUVs of malignant lesions was 6.04 ?± 3.22, that of nonmalignant lesions was 1.71 ?± 1.12, and the difference was significant (P = 0.0002). SUVs of all malignant lesions were greater than 2.0, and SUVs of all nonmalignant lesions, except the 1 case of ovarian fibroma, were less than 2.0. >Conclusion: 18F-FDG PET with continuous bladder irrigation is useful for eliminating 18F-FDG activity in the bladder and for differentiating between malignant and nonmalignant uterine or ovarian masses.
机译:id =“ p-1”>本研究的目的是使用 18 F-FDG连续膀胱冲洗以消除 18 F-FDG在膀胱中的活性。 >方法:研究了41例患者。他们有23个宫颈子宫病变(15例癌症,5例复发,3例未复发)。子宫体癌8例,其中2例复发;和10个卵巢肿块(6个恶性,4个非恶性)。所有癌症病例均经过组织学证实;但是,通过临床过程确诊了2例非复发性宫颈癌。静脉给药185-370 MBq 18 F-FDG后连续35-55分钟进行膀胱冲洗,静脉给药后40-55分钟进行放射扫描。采用标准摄取值(SUV)定量估算 18 F-FDG摄取程度。 >结果:膀胱冲洗后,33例患者尿路中的 18 F-FDG活性被消除,从而检测出肿瘤 18 F -FDG的积累很容易。 2名患者在膀胱中表现出残余活性,而6名患者在输尿管中表现出活性。在1例患者中发现了伪影,其原因是冲洗不充分导致膀胱残余活性。但是,这些残留活性对检测肿瘤中 18 F-FDG的积累没有影响。恶性病变SUV的平均值(?±SD)为6.04±3.22,非恶性病变SUV的平均值(?±SD)为1.71±1.12,差异有统计学意义( P = 0.002)。除1例卵巢纤维瘤外,所有恶性病变的SUV均大于2.0,所有非恶性病变的SUV均小于2.0。 >结论: 18 F-FDG PET连续膀胱冲洗可消除膀胱中的 18 F-FDG活性,并有助于区分恶性和恶性。非恶性子宫或卵巢肿块。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号